For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians. Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined ...
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has ...
Dealbreaker on MSN
Liquid biopsy firm Freenome finds a way to the public markets via $330M SPAC merger
Freenome’s SPAC merger agreement comes as the liquid biopsy developer prepares for potential 2026 commercialization of ...
Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws LOS ANGELES--(BUSINESS WIRE)--Researchers at ...
CNW/ - Syantra, Inc., a biotechnology company revolutionizing cancer detection, is announcing Scottsdale, Arizona based ...
A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...
FANSS study data presented at ESMO Asia 2025 demonstrate the feasibility of screening Asian women who do not smokePALO ALTO, Calif., Dec. 5, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback